Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Open Price
1557.90Prev. Close
1467.0000Volume
67013.00Value
106537267.40Fundamentals
Market Cap Cr
16631.90
Price to Earnings
54.00
Price to Book Value
10.90
Dividend Yield
0.60
PE to Growth
1.90
Op Revenue TTM Cr
1016.94
Net Profit TTM Cr
308.10
Cash From Operating Activity Cr
265.47
Return on Equity %
20.18
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
43.4
Week
51.7
Month
56.1
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1579.25
PIVOT
First Resistance
1608.50
Second Resistance
1627.20
Third Resistance
1656.45
First Support
1560.55
Second Support
1531.30
Third Support
1512.60
Relative Strength Index
60.06
Money Flow Index
73.62
MACD
19.26
MACD Signal
13.59
Average True Range
56.72
Average Directional Index
12.87
Rate of Change (21)
9.88
Rate of Change (125)
7.46
Commodity Channel Index
102.6
Williams %R
-4.9
BETA
1 Month
0.45
3 Month
0.35
1 Year
3 Year
PRICE CHANGE ANALYSIS
↑ 3.15%
1 Week
Low
High
1460.5
1597.95
↑ 8.63%
1 Month
Low
High
1327.05
1597.95
↑ 6.8%
3 Months
Low
High
1327.05
1725
↑ 5.09%
6 Months
Low
High
1327.05
1725
↑ 114.55%
1 Year
Low
High
900.05
1725
02 Jul 2024
Concord Biotech Ltd - 543960 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44(3) of SEBI LODR 2015, Please find the attached voting results bearing details of remote e voting and e voting during the AGM which conducted only through electronic means. We are also enclosing scrutinizer report on e-voting . Kindly take the same on records
01 Jul 2024
Concord Biotech Ltd - 543960 - Reg. 34 (1) Annual Report.
Annual Report enlcosed for FY 23-24
01 Jul 2024
Concord Biotech Ltd - 543960 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report
29 Jun 2024
Concord Biotech Ltd - 543960 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Regulation 30 of the SEBI (LODR) regulation 2015, we hereby enclose the summary of the proceedings of AGM held on saturday, 29 June, 2024 through Video Conferencin (VC)/ other audio visual means (OAVM). Kindly take on your records.
28 Jun 2024
Concord Biotech Ltd - 543960 - Closure of Trading Window
The trading window for dealing in the securities of the company will be closed for all Designated persons and their immediate relatives with effect from 1st july, 2024 and the same will remain closed till 48 hours after the announcement of unaudited financial results for the quarter ended on 30th june, 2024. Kindly take on the records.
07 Jun 2024
Concord Biotech Ltd - 543960 - Reg. 34 (1) Annual Report.
Annual report-Disclosure under regulation 34 of SEBI (LODR) regulation, 2015
07 Jun 2024
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation 30 of SEBI (LODR), please find the enclosed notices given to shareholders in accordance with applicable provision of SEBI listing regulation and the companies Act 2013 read with rules made thereunder, inter alia, informing them about 39th annual general meeting of the company and details relating to e-voting facility.
05 Jun 2024
Concord Biotech Ltd - 543960 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.- Intimation About EUGMP Certificate Issued By Health Product Regulatory Authority Of Ireland For Valthera Facility (Unit II) Of The Company
Intimation about EUGMP Certificate issued by Health Product Regulatory Authority of Ireland for Valthera Facility (Unit II) of the Company. Kindly take the above information on record.
04 Jun 2024
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/ Institutional Investor Meetings under SEBI (LODR) regulation, 2015
